Literature DB >> 20010455

Retinopathy of prematurity and maternal age.

Wei-Chi Wu1, Frank Shih-Chang Ong, Jane Zea-Chin Kuo, Chi-Chun Lai, Ning-Chia Wang, Kuan-Jen Chen, Yih-Shiou Hwang, Tun-Lu Chen, Chia-Pang Shih.   

Abstract

PURPOSE: To determine the risk factors, especially maternal risk factors, associated with the development of retinopathy of prematurity (ROP) in premature babies.
METHODS: A matched case-control study involving premature patients was undertaken retrospectively. The case group consisted of premature babies with the subsequent development of ROP. The control group consisted of gestational age-matched and sex-matched premature babies that did not develop ROP during the follow-up period. Risk factors involving patient demographics and maternal characteristics were compared between the case and control groups.
RESULTS: A total of 144 patients were included in this study (72 patients in the case group and 72 patients in the control group). Among the 66 possible risk factors compared, only birth weight and maternal age were found to be significant risk factors. Birth weight was significantly lower in the case group (1,248.7 +/- 257.8 g vs. 1,335.5 +/- 297.2 g, P = 0.01), and maternal age was significantly older in the case group compared with that in the control group (31.2 +/- 5.1 years vs. 28.2 +/- 5.3 years, P < 0.001). The odds ratio of having babies with ROP was 2.9 when the maternal age was >30 years.
CONCLUSION: Older maternal age is a newly identified risk factor for the development of ROP in premature babies.

Entities:  

Mesh:

Year:  2010        PMID: 20010455      PMCID: PMC2958776          DOI: 10.1097/IAE.0b013e3181ba246f

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  37 in total

1.  Intraventricular haemorrhage and stage 3 retinopathy of prematurity.

Authors:  P Watts; G G Adams; R M Thomas; C Bunce
Journal:  Br J Ophthalmol       Date:  2000-06       Impact factor: 4.638

2.  In vitro fertilisation and stage 3 retinopathy of prematurity.

Authors:  P Watts; G G Adams
Journal:  Eye (Lond)       Date:  2000-06       Impact factor: 3.775

Review 3.  The maternal age effect: a hypothesis based on oxidative phosphorylation.

Authors:  Martin Wilding; Loredana Di Matteo; Brian Dale
Journal:  Zygote       Date:  2005-11       Impact factor: 1.442

4.  Maternal age and malformations in singleton births.

Authors:  L M Hollier; K J Leveno; M A Kelly; D D MCIntire; F G Cunningham
Journal:  Obstet Gynecol       Date:  2000-11       Impact factor: 7.661

5.  Risk factors in retinopathy of prematurity. a multivariate statistical analysis.

Authors:  V Seiberth; O Linderkamp
Journal:  Ophthalmologica       Date:  2000       Impact factor: 3.250

6.  Retinal phenotype-genotype correlation of pediatric patients expressing mutations in the Norrie disease gene.

Authors:  Wei-Chi Wu; Kimberly Drenser; Michael Trese; Antonio Capone; Wendy Dailey
Journal:  Arch Ophthalmol       Date:  2007-02

7.  Risk factors in the development of mild and severe retinopathy of prematurity.

Authors:  Imren Akkoyun; Sibel Oto; Gursel Yilmaz; Berkan Gurakan; Aylin Tarcan; Deniz Anuk; Seval Akgun; Yonca A Akova
Journal:  J AAPOS       Date:  2006-10       Impact factor: 1.220

Review 8.  Genetic screening and counseling.

Authors:  Mary E Norton
Journal:  Curr Opin Obstet Gynecol       Date:  2008-04       Impact factor: 1.927

Review 9.  Meiosis in oocytes: predisposition to aneuploidy and its increased incidence with age.

Authors:  Keith T Jones
Journal:  Hum Reprod Update       Date:  2007-12-14       Impact factor: 15.610

10.  Analysis of seven maternal polymorphisms of genes involved in homocysteine/folate metabolism and risk of Down syndrome offspring.

Authors:  Iris Scala; Barbara Granese; Maria Sellitto; Serena Salomè; Annalidia Sammartino; Antonio Pepe; Pierpaolo Mastroiacovo; Gianfranco Sebastio; Generoso Andria
Journal:  Genet Med       Date:  2006-07       Impact factor: 8.822

View more
  7 in total

Review 1.  Retinopathy of prematurity: a review of risk factors and their clinical significance.

Authors:  Sang Jin Kim; Alexander D Port; Ryan Swan; J Peter Campbell; R V Paul Chan; Michael F Chiang
Journal:  Surv Ophthalmol       Date:  2018-04-19       Impact factor: 6.048

2.  Effects of maternal and placental inflammation on retinopathy of prematurity.

Authors:  Se Joon Woo; Kyo Hoon Park; Hee Jung Jung; Shi nae Kim; Gheeyoung Choe; Jeeyun Ahn; Kyu Hyung Park
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-04-01       Impact factor: 3.117

Review 3.  Current update on retinopathy of prematurity: screening and treatment.

Authors:  Jing Chen; Andreas Stahl; Ann Hellstrom; Lois E Smith
Journal:  Curr Opin Pediatr       Date:  2011-04       Impact factor: 2.856

Review 4.  The role of anti-vascular endothelial growth factor in treatment of retinopathy of prematurity-a current review.

Authors:  Shing Chuen Chow; Pun Yuet Lam; Wai Ching Lam; Nicholas Siu Kay Fung
Journal:  Eye (Lond)       Date:  2022-01-11       Impact factor: 4.456

5.  Role of Serum Levels of Vascular Endothelial Growth Factor and Its Receptor in Retinopathy of Prematurity.

Authors:  Binita Goswami; Monika Goyal; Sarita Beri; Rajiv Garg; Arvind Saili; Anju Jain
Journal:  Iran J Pediatr       Date:  2015-08-24       Impact factor: 0.364

6.  Risk factors for retinopathy of prematurity in a district in South India: A prospective cohort study.

Authors:  Ashish A Ahuja; Yerahaia C V Reddy; Olukorede O Adenuga; Dheeraj Kewlani; Meenakshi Ravindran; Rengappa Ramakrishnan
Journal:  Oman J Ophthalmol       Date:  2018 Jan-Apr

7.  Association of Maternal Age to Development and Progression of Retinopathy of Prematurity in Infants of Gestational Age under 33 Weeks.

Authors:  Atsuro Uchida; Masayuki Miwa; Hajime Shinoda; Takashi Koto; Norihiro Nagai; Hiroshi Mochimaru; Yohei Tomita; Mariko Sasaki; Kazushige Ikeda; Kazuo Tsubota; Yoko Ozawa
Journal:  J Ophthalmol       Date:  2014-04-30       Impact factor: 1.909

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.